The Lamb Law Office Newsletter is a monthly communication from our law firm to help keep you up to date with some of the cases that we are working on for clients at the present time. In addition, we provide at least one information resource item per month, which you or someone you know might find helpful from time to time.
Past Newsletter Topics
Here are just a few of the topics we have written about in the past.
Beovu Causing Vision Loss or Blindness
Since January 2021, Beovu lawsuits have been filed against Novartis, the pharmaceutical company responsible for Beovu, due to a failure to properly warn doctors and patients about adverse Beovu side effects, which can lead to severe vision loss and blindness.
The first two of these Beovu lawsuits in the country were filed on behalf of our clients, with more to follow in the future. Our law firm is investigating possible Beovu lawsuits for patients who have suffered vision loss or blindness after their Beovu injections.
Asbestos-Contaminated Talcum Powder Causing Mesothelioma
It has been argued in recent lawsuits that products containing asbestos-contaminated talcum powder can cause mesothelioma. Personal injury and wrongful death product liability lawsuits have been filed against the manufacturers and distributors of these products.
Our law firm is investigating possible asbestos-mesothelioma lawsuits for people who have been diagnosed with mesothelioma who have used talcum powder products in the past that may have contained asbestos.
SGLT2 Inhibitors Causing Fournier’s Gangrene
Invokana, Farxiga, and Jardiance are popular diabetes drugs that are classified as Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors. Other drugs in the SGLT2 Inhibitors class, which have been increasingly prescribed for treatment of Type-2 diabetes in recent years, are Invokamet, Xigduo, Glyxambi, Synjardy, Qtern, Steglatro, Steglujan, and Segluromet.
In 2018 the FDA warned doctors and patients about the association between Invokana, Farxiga, and Jardiance, as well as the other SGLT2 inhibitors, and Fournier’s Gangrene, a dangerous form of necrotizing fasciitis. This is a potentially life-threatening medical condition that almost always requires hospitalization and surgical procedures. In more detail, Fournier’s Gangrene — which is sometimes called Necrotizing Fasciitis of the Perineum — involves the genital, perineal, or perianal regions of the body, killing soft tissues, including muscles, nerves, and blood vessels.
We are currently investigating possible drug injury lawsuits against the responsible pharmaceutical companies for diabetes patients who have been diagnosed with Fournier’s Gangrene or Necrotizing Faciitis of the Perineum.
Past Newsletter Editions
For your convenience, below we have presented a summary and link for the most recent editions of the Lamb Law Office Newsletter.
February 2021 – In this newsletter, we cover three litigations we are currently handling including Xeljanz, Beovu, and Asbestos in Talcum Powder Products. We also provide readers with information regarding individuals’ rights under HIPPA to access their health information.
January 2021 – In this newsletter, we provide readers with a brief overview of our current Drug Injury Lawsuits. We also provide information clarifying the differences between drug interactions, side effects, and allergies. Lastly, there is information from the CDC about the COVID-19 Vaccine.
December 2020 – In this newsletter, we cover the drug injury litigation regarding the SGLT2 Inhibitors class of diabetes drugs (Inovanka, Farxiga, Jardiance, etc.). We also provide information on how to report adverse drug reactions to the FDA MedWatch Program. In addition, we point out the updated CDC Domestic Travel Guidelines.
November 2020 – In this newsletter, we cover two different litigations which we are currently handling, Injectafer and GenX. We also provide information regarding CDC Holiday Gathering Recommendations.
October 2020 – In this newsletter, we cover these three litigation areas: Asbestos – Mesothelioma; Benzene; and, Belviq. We also provide information for Medline Plus, a free online health information resource.
September 2020 – In this newsletter, we cover a few litigations we are currently handling, Breast Implant Devices, Elmiron, and Beovu. We also provide information regarding medical record copying costs by state.
Newsletter Sign-up Form
You can sign up to receive our monthly newsletter by completing this form.